Silvia Giordano

ORCID: 0009-0007-0193-1180
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hidradenitis Suppurativa and Treatments
  • Chemotherapy-related skin toxicity
  • Occupational and environmental lung diseases
  • Dupuytren's Contracture and Treatments
  • Microscopic Colitis
  • Lymphoma Diagnosis and Treatment
  • Microbial infections and disease research
  • Cutaneous lymphoproliferative disorders research
  • CAR-T cell therapy research
  • Otolaryngology and Infectious Diseases
  • Bacterial Infections and Vaccines
  • Autoimmune and Inflammatory Disorders
  • Oral Health Pathology and Treatment

University of Turin
2024-2025

University of Milan
2004-2005

Introduction: Psoriasis and hidradenitis suppurativa (HS) are chronic inflammatory diseases with significant overlap in their immunologic pathways, which involve cytokines such as tumor necrosis factor-alfa, interleukin (IL)-17, IL-23. Current treatment options for HS limited, only adalimumab secukinumab approved severe cases. Given the overlapping pathogenetic features between psoriasis, anti-IL-17 anti-IL-23 drugs could represent valuable treatments management of HS. Objectives: We sought...

10.5826/dpc.1404a250 article EN cc-by-nc Dermatology Practical & Conceptual 2024-10-30

Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma (CTCL) that typically presents in early phase as inflammatory erythematous patches or plaques, with epidermotropism histopathological hallmark of disease. Traditionally, stages, non-aggressive options represent first-line strategy: topical corticosteroids, phototherapy, radiotherapy, and occasionally adopting a "wait-and-see" approach for minimally symptomatic patients. In patients advanced recurrent disease, good results...

10.4081/dr.2024.10002 article EN cc-by-nc Dermatology Reports 2024-10-02
Coming Soon ...